Amedeo Smart

Free Medical Literature Service

 

Amedeo

Cytomegalovirus Infection
  Free Subscription

Articles published in
J Virol
    March 2026
  1. SHIN K, Kim ET
    Viral genome editing methods and applications in the CRISPR era.
    J Virol. 2026;100:e0204825.
    >> Share

    December 2025
  2. PETERSON CS, Bailey IT, Lanchy J-M, Gallego I, et al
    Interstrain recombinants of human cytomegalovirus uncouple glycoprotein display, virion infectivity, and spread characteristics.
    J Virol. 2025 Dec 30:e0159225. doi: 10.1128/jvi.01592.
    >> Share

  3. CORTEZ RAYAS L, Rogg R, Voll M, Thompson C, et al
    Initiation of human cytomegalovirus secondary envelopment requires the gM/gN glycoprotein complex and involves palmitoylation.
    J Virol. 2025 Dec 8:e0156725. doi: 10.1128/jvi.01567.
    >> Share

    November 2025
  4. GONG S, Park D, Chung W-C, Ahn J-H, et al
    Evidence for G-quadruplex-mediated transactivation by the immediate-early 2 protein of human cytomegalovirus.
    J Virol. 2025 Nov 25:e0146725. doi: 10.1128/jvi.01467.
    >> Share

  5. FONSECA BRITO L, Ostermann E, Kottlau J, Todter S, et al
    Neuropilin-1 expression modulates infection susceptibility to murine cytomegalovirus at the materno-fetal interface.
    J Virol. 2025 Nov 25:e0161025. doi: 10.1128/jvi.01610.
    >> Share

  6. COX JB, Murphy EA
    Protein-S-nitrosylation of adenovirus-5 E1A and human papillomavirus 16 E7 limits their ability to inhibit STING activity.
    J Virol. 2025;99:e0145625.
    >> Share

  7. GEILER BW, Moradpour S, Chauder BB, Akter D, et al
    Human cytomegalovirus-triggered necroptosis is suppressed by sequestration of MLKL in the nucleus of infected monocytes.
    J Virol. 2025 Nov 5:e0102025. doi: 10.1128/jvi.01020.
    >> Share

    October 2025
  8. GOURIN C, Di Meo F, Delmon C, Alain S, et al
    Functional and structural insights into HCMV terminase accessory proteins pUL77 and pUL93.
    J Virol. 2025;99:e0117325.
    >> Share

  9. MEDICA S, Diggins NL, Denton M, Turner RL, et al
    Human cytomegalovirus UL78 is a nuclear-localized GPCR necessary for efficient reactivation from latent infection in CD34(+) hematopoietic progenitor cells.
    J Virol. 2025 Oct 8:e0140225. doi: 10.1128/jvi.01402.
    >> Share

    September 2025
  10. GULIJIAHANI A, Arii J, Isakovic V, Huang JR, et al
    ESCRT-III is recruited by human herpesvirus 6A nuclear egress complex to promote nuclear egress of the nucleocapsid.
    J Virol. 2025;99:e0084425.
    >> Share

  11. BARUAH V, O'Connor CM
    The BTK-DDX41 axis of the STING pathway is activated during cytomegalovirus lytic infection.
    J Virol. 2025 Sep 16:e0104825. doi: 10.1128/jvi.01048.
    >> Share

    August 2025
  12. OSANYINLUSI SA, Baruah V, Groves IJ, Kulp KH, et al
    Human cytomegalovirus-encoded G protein-coupled receptor (GPCR) UL78 regulates viral reactivation.
    J Virol. 2025 Aug 27:e0105725. doi: 10.1128/jvi.01057.
    >> Share

  13. KLINE I, Mokry RL, Xi Y, Passols Manzano M, et al
    Human cytomegalovirus promotes de novo PC synthesis during early virus replication.
    J Virol. 2025 Aug 19:e0057925. doi: 10.1128/jvi.00579.
    >> Share

  14. KUMAR R, Reider IE, Martin M, Simpson JS, et al
    The HCMV tegument protein UL88 degrades MyD88 and reduces innate immune activation.
    J Virol. 2025;99:e0041425.
    >> Share

  15. ZHOU X, Yang L, Cimato G, Frascaroli G, et al
    Increased infectivity of human cytomegalovirus strain TB40/E conferred by variants of the envelope glycoprotein UL128 and the regulatory protein IE2.
    J Virol. 2025 Aug 11:e0064225. doi: 10.1128/jvi.00642.
    >> Share

    July 2025
  16. HANCOCK MH, Caposio P, Collins-McMillen D, Diggins NL, et al
    Cytomegalovirus latency-the sum of subtleties.
    J Virol. 2025 Jul 30:e0066425. doi: 10.1128/jvi.00664.
    >> Share

    June 2025
  17. SCHLEISS MR, Fernandez-Alarcon C, Bierle CJ, Geballe AP, et al
    Replication-deficient whole-virus vaccines against cytomegalovirus induce protective immunity in a guinea pig congenital infection model.
    J Virol. 2025 Jun 11:e0020725. doi: 10.1128/jvi.00207.
    >> Share

    May 2025
  18. STALIUNAITE L, Puhach O, Ostermann E, Rosenke K, et al
    Molecular cloning and host range analysis of three cytomegaloviruses from Mastomys natalensis.
    J Virol. 2025;99:e0214724.
    >> Share

  19. KARTHIGEYAN KP, Connors M, Binuya CR, Gross M, et al
    A human cytomegalovirus prefusion-like glycoprotein B subunit vaccine elicits humoral immunity similar to that of postfusion gB in mice.
    J Virol. 2025 May 8:e0217824. doi: 10.1128/jvi.02178.
    >> Share

    April 2025
  20. COX JB, Nukui M, Murphy EA
    Protein-S-nitrosylation of human cytomegalovirus pp65 reduces its ability to undermine cGAS.
    J Virol. 2025 Apr 17:e0048125. doi: 10.1128/jvi.00481.
    >> Share

  21. WU C, Johnson NM, Yu S, Lo AS, et al
    Persistence of CMV-specific anti-HIV CAR T cells after adoptive immunotherapy.
    J Virol. 2025 Apr 10:e0193324. doi: 10.1128/jvi.01933.
    >> Share

  22. SCHULTZ EP, Ponsness L, Lanchy J-M, Zehner M, et al
    Human cytomegalovirus gH/gL/gO binding to PDGFRalpha provides a regulatory signal activating the fusion protein gB that can be blocked by neutralizing antibodies.
    J Virol. 2025 Apr 9:e0003525. doi: 10.1128/jvi.00035.
    >> Share

    March 2025
  23. HARMENING S, Bogdanow B, Wagner K, Liu F, et al
    Interaction of human cytomegalovirus pUL52 with major components of the viral DNA encapsidation network underlines its essential role in genome cleavage-packaging.
    J Virol. 2025 Mar 10:e0220124. doi: 10.1128/jvi.02201.
    >> Share

    February 2025
  24. MARTIN M, Kumar R, Buchkovich NJ, Norbury CC, et al
    HCMV infection downregulates GPX4 and stimulates lipid peroxidation but does not induce ferroptosis.
    J Virol. 2025;99:e0185124.
    >> Share

  25. CAVANAUGH CM, Betsinger CN, Katchur N, Zhang S, et al
    Effect of host telomerase inhibition on human cytomegalovirus.
    J Virol. 2025 Feb 5:e0157824. doi: 10.1128/jvi.01578.
    >> Share

  26. DUNN DM, Pack LJ, Munger JC
    RAF1 promotes successful human cytomegalovirus replication and is regulated by AMPK-mediated phosphorylation during infection.
    J Virol. 2025 Feb 4:e0186624. doi: 10.1128/jvi.01866.
    >> Share

    January 2025
  27. MEDICA S, Denton M, Diggins NL, Kramer-Hansen O, et al
    Third intracellular loop of HCMV US28 is necessary for signaling and viral reactivation.
    J Virol. 2025;99:e0180124.
    >> Share

  28. CATALDO KM, Roche KL, Monti CE, Dash RK, et al
    The effective multiplicity of infection for HCMV depends on the activity of the cellular 20S proteasome.
    J Virol. 2025;99:e0175124.
    >> Share

    November 2024
  29. HOFSTADTER WA, Park JW, Lum KK, Chen S, et al
    HCMV strain- and cell type-specific alterations in membrane contact sites point to the convergent regulation of organelle remodeling.
    J Virol. 2024;98:e0109924.
    >> Share

  30. OSTERMANN E, Luoto L-M, Clausen M, Virdi S, et al
    E2F3-dependent activation of FAM111B restricts mouse cytomegalovirus replication in primate cells.
    J Virol. 2024 Nov 4:e0134924. doi: 10.1128/jvi.01349.
    >> Share

    October 2024
  31. LENARCIC EM, Hale AE, Vincent HA, Dickmander RJ, et al
    Protein phosphatase 1 suppresses PKR/EIF2alpha signaling during human cytomegalovirus infection.
    J Virol. 2024 Oct 29:e0059024. doi: 10.1128/jvi.00590.
    >> Share

  32. GROVES IJ, O'Connor CM
    Loopy virus or controlled contortionist? 3D regulation of HCMV gene expression by CTCF-driven chromatin interactions.
    J Virol. 2024;98:e0114824.
    >> Share

    September 2024
  33. ZHANG W, Nilles TL, Bream JH, Li H, et al
    Breadth and polyfunctionality of T cell responses to human cytomegalovirus in men who have sex with men: relationship with HIV infection and frailty.
    J Virol. 2024 Sep 4:e0116724. doi: 10.1128/jvi.01167.
    >> Share

    August 2024
  34. BRACKENRIDGE S, John N, He W, Fruh K, et al
    Regulation of the cell surface expression of classical and non-classical MHC proteins by the human cytomegalovirus UL40 and rhesus cytomegalovirus Rh67 proteins.
    J Virol. 2024 Aug 29:e0120624. doi: 10.1128/jvi.01206.
    >> Share

  35. CAI X, Padilla NT, Rosbe K, Tugizov SM, et al
    Breast milk induces the differentiation of monocytes into macrophages, promoting human cytomegalovirus infection.
    J Virol. 2024 Aug 28:e0117724. doi: 10.1128/jvi.01177.
    >> Share

    July 2024
  36. ATANASOFF KE, Parsons AJ, Ophir SI, Lurain N, et al
    A broadly neutralizing human monoclonal antibody generated from transgenic mice immunized with HCMV particles limits virus infection and proliferation.
    J Virol. 2024;98:e0021324.
    >> Share

    June 2024
  37. CIMATO G, Zhou X, Brune W, Frascaroli G, et al
    Human cytomegalovirus glycoprotein variants governing viral tropism and syncytium formation in epithelial cells and macrophages.
    J Virol. 2024 Jun 5:e0029324. doi: 10.1128/jvi.00293.
    >> Share

    April 2024
  38. DOMANICO LF, Dunn GP, Kobiler O, Taylor MP, et al
    A dual fluorescent herpes simplex virus type 1 recombinant reveals divergent outcomes of neuronal infection.
    J Virol. 2024 Apr 23:e0003224. doi: 10.1128/jvi.00032.
    >> Share

  39. COPLEN CP, Jergovic M, Terner EL, Bradshaw CM, et al
    Virological, innate, and adaptive immune profiles shaped by variation in route and age of host in murine cytomegalovirus infection.
    J Virol. 2024 Apr 15:e0198623. doi: 10.1128/jvi.01986.
    >> Share

    March 2024
  40. WU K, Hou YJ, Makrinos D, Liu R, et al
    Characterization of humoral and cellular immunologic responses to an mRNA-based human cytomegalovirus vaccine from a phase 1 trial of healthy adults.
    J Virol. 2024 Mar 25:e0160323. doi: 10.1128/jvi.01603.
    >> Share

  41. ROLLMAN TB, Berkebile ZW, Okae H, Bardwell VJ, et al
    Human trophoblast stem cells restrict human cytomegalovirus replication.
    J Virol. 2024 Mar 7:e0193523. doi: 10.1128/jvi.01935.
    >> Share

    February 2024
  42. KAWASAKI H, Hariyama T, Kosugi I, Meguro S, et al
    Human induced pluripotent stem cells are resistant to human cytomegalovirus infection primarily at the attachment level due to the reduced expression of cell-surface heparan sulfate.
    J Virol. 2024 Feb 12:e0127823. doi: 10.1128/jvi.01278.
    >> Share

    January 2024
  43. MILLER MJ, Akter D, Mahmud J, Chan GC, et al
    Human cytomegalovirus modulates mTORC1 to redirect mRNA translation within quiescently infected monocytes.
    J Virol. 2024 Jan 30:e0188823. doi: 10.1128/jvi.01888.
    >> Share

    October 2023
  44. DIRCK A, Diggins NL, Crawford LB, Perez WD, et al
    HCMV UL8 interaction with beta-catenin and DVL2 regulates viral reactivation in CD34(+) hematopoietic progenitor cells.
    J Virol. 2023;97:e0124123.
    >> Share

  45. O'BRIEN BS, Mokry RL, Schumacher ML, Rosas-Rogers S, et al
    Neutralizing antibodies with neurotropic factor treatment maintain neurodevelopmental gene expression upon exposure to human cytomegalovirus.
    J Virol. 2023 Oct 5:e0069623. doi: 10.1128/jvi.00696.
    >> Share

    September 2023
  46. DOMMA AJ, Henderson LA, Goodrum FD, Moorman NJ, et al
    Human cytomegalovirus attenuates AKT activity by destabilizing insulin receptor substrate proteins.
    J Virol. 2023 Sep 27:e0056323. doi: 10.1128/jvi.00563.
    >> Share

    August 2023
  47. MOY MA, Collins-McMillen D, Crawford L, Parkins C, et al
    Stabilization of the human cytomegalovirus UL136p33 reactivation determinant overcomes the requirement for UL135 for replication in hematopoietic cells.
    J Virol. 2023 Aug 11:e0014823. doi: 10.1128/jvi.00148.
    >> Share

  48. FANUNZA E, Cheng AZ, Auerbach AA, Stefanovska B, et al
    Human cytomegalovirus mediates APOBEC3B relocalization early during infection through a ribonucleotide reductase-independent mechanism.
    J Virol. 2023 Aug 11:e0078123. doi: 10.1128/jvi.00781.
    >> Share

    June 2023
  49. MLERA L, Collins-McMillen D, Zeltzer S, Buehler JC, et al
    Liver X Receptor-Inducible Host E3 Ligase IDOL Targets a Human Cytomegalovirus Reactivation Determinant.
    J Virol. 2023 Jun 20:e0075823. doi: 10.1128/jvi.00758.
    >> Share

  50. KIM JJ, Hong S, Seo JY
    A Cysteine Residue of Human Cytomegalovirus vMIA Protein Plays a Crucial Role in Viperin Trafficking to Control Viral Infectivity.
    J Virol. 2023 Jun 12:e0187422. doi: 10.1128/jvi.01874.
    >> Share

  51. SCHWANKE H, Goncalves Magalhaes V, Schmelz S, Wyler E, et al
    The Cytomegalovirus M35 Protein Directly Binds to the Interferon-beta Enhancer and Modulates Transcription of Ifnb1 and Other IRF3-Driven Genes.
    J Virol. 2023 Jun 8:e0040023. doi: 10.1128/jvi.00400.
    >> Share

    May 2023
  52. IJEZIE EC, O'Dowd JM, Kuan MI, Faeth AR, et al
    HCMV Infection Reduces Nidogen-1 Expression, Contributing to Impaired Neural Rosette Development in Brain Organoids.
    J Virol. 2023;97:e0171822.
    >> Share

    April 2023
  53. FENG M, Chen M, Yuan Y, Liu Q, et al
    Interspecies/Intergroup Complementation of Orthotospovirus Replication and Movement through Reverse Genetics Systems.
    J Virol. 2023;97:e0180922.
    >> Share

  54. HUANG SN, Pan YT, Zhou YP, Wang XZ, et al
    Human Cytomegalovirus IE1 Impairs Neuronal Migration by Downregulating Connexin 43.
    J Virol. 2023 Apr 25:e0031323. doi: 10.1128/jvi.00313.
    >> Share

    March 2023
  55. GHOSH AK, Su YP, Forman M, Keyes RF, et al
    Harnessing the Noncanonical Keap1-Nrf2 Pathway for Human Cytomegalovirus Control.
    J Virol. 2023 Mar 20:e0016023. doi: 10.1128/jvi.00160.
    >> Share

  56. LISTA MJ, Witney AA, Nichols J, Davison AJ, et al
    Strain-Dependent Restriction of Human Cytomegalovirus by Zinc Finger Antiviral Proteins.
    J Virol. 2023 Mar 14:e0184622. doi: 10.1128/jvi.01846.
    >> Share

  57. ALBRIGHT ER, Walter RM, Saffert RT, Kalejta RF, et al
    NFkappaB and Cyclic AMP Response Element Sites Mediate the Valproic Acid and UL138 Responsiveness of the Human Cytomegalovirus Major Immediate Early Enhancer and Promoter.
    J Virol. 2023 Mar 1:e0002923. doi: 10.1128/jvi.00029.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016